Data gathered: April 21
AI Stock Analysis - Gilead Sciences (GILD)
Analysis generated March 11, 2025. Powered by Chat GPT.
Gilead Sciences, Inc. is an American biopharmaceutical company that focuses on the research, development, and commercialization of treatments for life-threatening diseases. Founded in 1987 and headquartered in Foster City, California, Gilead has grown into a prominent player in the biotechnology industry. The company’s portfolio includes treatments for HIV/AIDS, liver diseases, cancer, and inflammatory diseases. Gilead is known for its innovative approach to drug development, making it a key player in the healthcare sector.
Stock Alerts - Gilead Sciences (GILD)
 |
Gilead Sciences | April 17 Insider Alert: Dickinson Andrew D is selling shares |
|
Gilead Sciences | April 14 Jefferson Shreve (member of U.S. congress) is buying shares |
|
Gilead Sciences | April 11 Josh Gottheimer (member of U.S. congress) is buying shares |
|
Gilead Sciences | April 10 Price is down by -5% in the last 24h. |
Alternative Data for Gilead Sciences
About Gilead Sciences
Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.
| Price | $103.95 |
| Target Price | Sign up |
| Volume | 2,020,000 |
| Market Cap | $130B |
| Year Range | $71.98 - $116.58 |
| Dividend Yield | 3.02% |
| PE Ratio | 275.11 |
| Analyst Rating | 62% buy |
| Earnings Date | April 24 '25 |
| Industry | Biotechnology |
In the news
 |
XTX Topco Ltd Reduces Stake in Gilead Sciences, Inc. (NASDAQ:GILD)April 21 - ETF Daily News |
 |
Here's Why Gilead Sciences (GILD) is a Strong Value StockApril 17 - Yahoo |
|
What Analyst Projections for Key Metrics Reveal About Gilead (GILD) Q1 EarningsApril 17 - Yahoo |
|
Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?April 17 - Yahoo |
|
Gilead Sciences (GILD) Reports Next Week: Wall Street Expects Earnings GrowthApril 17 - Yahoo |
|
Gilead Sciences (GILD) Stock Moves -0.74%: What You Should KnowApril 16 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 7.57B | 1.58B | 5.99B | 1.78B | 3.11B | 1.900 |
| Q3 '24 | 7.55B | 1.57B | 5.97B | 1.25B | 1.88B | 2.020 |
| Q2 '24 | 6.95B | 1.54B | 5.41B | 1.61B | 2.98B | 2.010 |
| Q1 '24 | 6.69B | 1.55B | 5.13B | -4.17B | -3.54B | -1.320 |
| Q4 '23 | 7.12B | 1.56B | 5.56B | 1.43B | 2.59B | 1.720 |
Insider Transactions View All
| Dickinson Andrew D filed to sell 168,174 shares at $106.4. April 16 '25 |
| Dickinson Andrew D filed to sell 170,674 shares at $110.5. March 18 '25 |
| Dickinson Andrew D filed to sell 182,074 shares at $117.3. March 12 '25 |
| Dickinson Andrew D filed to sell 169,061 shares at $118.5. March 12 '25 |
| Dickinson Andrew D filed to sell 169,061 shares at $104.1. February 19 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Jefferson Shreve |
Apr 14, 25 | Buy | $15K - $50K |
| Carol Devine Miller |
Apr 11, 25 | Buy | $1K - $15K |
| Josh Gottheimer |
Apr 11, 25 | Buy | $1K - $15K |
Read more about Gilead Sciences (GILD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Gilead Sciences?
The Market Cap of Gilead Sciences is $130B.
What is Gilead Sciences' PE Ratio?
As of today, Gilead Sciences' PE (Price to Earnings) ratio is 275.11.
When does Gilead Sciences report earnings?
Gilead Sciences will report its next earnings on April 24 '25.
What is the current stock price of Gilead Sciences?
Currently, the price of one share of Gilead Sciences stock is $103.95.
How can I analyze the GILD stock price chart for investment decisions?
The GILD stock price chart above provides a comprehensive visual representation of Gilead Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Gilead Sciences shares. Our platform offers an up-to-date GILD stock price chart, along with technical data analysis and alternative data insights.
Does GILD offer dividends to its shareholders?
Yes, Gilead Sciences (GILD) offers dividends to its shareholders, with a dividend yield of 3.02%. This dividend yield represents Gilead Sciences' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Gilead Sciences in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Gilead Sciences?
Some of the similar stocks of Gilead Sciences are Amgen, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Anavex Life Sciences, and BridgeBio Pharma.
.